Peer review reports
From: N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms
Original Submission |
19 Jul 2016 |
Submitted |
Original manuscript
|
|
Author responded |
Author comments
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
|
Author responded |
Author comments
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
Publishing |
6 Sep 2016 |
Editorially accepted |
|
15 Sep 2016 |
Article published |
10.1186/s12888-016-1030-3
|
Learn about peer review